Emphysema Treatment Global Market Report 2026

Description

Emphysema treatment involves medications and therapies used to manage chronic obstructive pulmonary disease (COPD), a condition that damages the air sacs in the lungs and makes breathing difficult. Treatments for emphysema are aimed at controlling symptoms and slowing the progression of the disease.

The main treatment options for emphysema include smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, surgical procedures, lung transplants, and others. Smoking cessation refers to the process of quitting smoking to lower the risk of cancer and other serious health problems by reducing cravings and withdrawal symptoms while preventing nicotine binding. These treatments are distributed through channels such as online providers, drug stores and retail pharmacies, and hospital pharmacies, and are used by various end users including clinics, surgical centers, and others.

Tariffs have impacted the emphysema treatment market by increasing costs of imported medical devices, drugs, and gene therapy components, disrupting the global supply chain. Bronchodilators, supplemental oxygen systems, and advanced therapies are most affected, particularly in North America and Asia-Pacific regions. Some companies are localizing manufacturing and sourcing to mitigate price hikes, which can also accelerate domestic innovation. While tariffs create cost challenges, they may encourage investments in regional production and self-sufficiency in high-value treatments.

The emphysema treatment market research report is one of a series of new reports from The Business Research Company that provides emphysema treatment market statistics, including emphysema treatment industry global market size, regional shares, competitors with a emphysema treatment market share, detailed emphysema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the emphysema treatment industry. This emphysema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emphysema treatment market size has grown strongly in recent years. It will grow from $5.4 billion in 2025 to $5.8 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing prevalence of copd, growing smoking population, limited awareness of early diagnosis, traditional inhalation therapies adoption, rising hospital infrastructure in developing regions.

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to advancements in gene therapy, rising adoption of digital health solutions, growing home healthcare services, development of portable oxygen devices, increasing demand for minimally invasive surgeries. Major trends in the forecast period include personalized treatment plans, home-based care solutions, minimally invasive therapies, telehealth & remote monitoring, advanced pulmonary rehabilitation programs.

The increasing prevalence of chronic obstructive pulmonary disease (COPD) cases is anticipated to drive the growth of the emphysema treatment market in the coming years. Chronic obstructive pulmonary disease is a group of progressive lung disorders that cause airflow limitation and breathing difficulties, primarily including emphysema and chronic bronchitis. Emphysema treatments play a vital role in managing COPD by alleviating symptoms, improving lung function, and slowing disease progression. For example, in December 2023, according to a research study published by JAMA Network Open, a medical journal of the American Medical Association, the global burden of COPD was projected to rise significantly, with cases worldwide expected to reach nearly 600 million by 2050, representing a 23% increase in prevalence. As a result, the rising prevalence of COPD is contributing to the expansion of the emphysema treatment market.

Major companies operating in the emphysema treatment market are focusing on the development of innovative products, such as inhalation aerosols, to strengthen their competitive position. Inhalation aerosols are pharmaceutical formulations delivered as a fine mist or spray, allowing medications to reach the lungs directly for effective symptom control. For instance, in July 2023, Viatris Inc., in collaboration with Kindeva Drug Delivery L.P., launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This product became the first FDA-approved generic version of AstraZeneca's Symbicort for the management of asthma, chronic obstructive pulmonary disease, and emphysema. Available in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg strengths, this drug-device combination represents a significant step toward providing more affordable and accessible respiratory treatments. Breyna is indicated for maintenance therapy to manage airflow obstruction, reduce COPD exacerbations, and control asthma symptoms in patients aged six years and older, including those with emphysema.

In March 2023, UC Davis Health, a US-based academic health institution, partnered with Propeller Health to deliver personalized care for patients with chronic obstructive pulmonary disease and asthma using remote patient monitoring technology. Through this collaboration, eligible patients received access to Propeller Health's remote monitoring services, which combine sensors, a smartphone application, and a web platform to support individualized treatment for high-risk COPD and asthma patients, including those affected by emphysema.

Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.

North America was the largest region in the emphysema treatment market in 2025. The regions covered in the emphysema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the emphysema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emphysema treatment market includes revenues earned by entities by providing medical services such as bronchodilator medications, anti-inflammatory medication, oxygen therapy, lifestyle change consultation, and interventional therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emphysema Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses emphysema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The emphysema treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Treatment: Smoking Cessation; Bronchodilators; Steroids; Leukotriene Modifiers; Supplemental Oxygen; Antibiotics; Gene Therapy; Surgery Transplant; Other Treatments
2) By Distribution Channel: Online Providers; Drug Stores and Retail Pharmacies; Hospital Pharmacies
3) By End-User: Clinics; Surgical Centre; Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT); Prescription Medications; Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs); Long-Acting Beta-Agonists (LABAs); Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS); Oral Corticosteroids; Combination Inhalers
4) By Leukotriene Modifiers: Montelukast; Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators; Continuous Flow Oxygen Systems; Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides; Fluoroquinolones; Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy; Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS); Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs; Nutritional Support; Palliative Care
Companies Mentioned: AstraZeneca PLC; Teva Pharmaceutical Industries Ltd.; Novartis AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC; Boehringer Ingelheim GmbH; Mylan N.V.; Pfizer Inc.; Orion Oyj; Verona Pharma PLC; Pulmonx Corporation; Emphasys Medical Inc.; Respinova Ltd; Gala Therapeutics Inc.; Pulmatrix Inc.; Broncus Medical Inc.; Holaira Inc.; PneumRx Inc.; Spiration Inc.; Aeris Therapeutics Inc.; CSA Medical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4METRE01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Emphysema Treatment Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Emphysema Treatment Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Emphysema Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Emphysema Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Autonomous Systems, Robotics & Smart Mobility
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Personalized Treatment Plans
- 4.2.2 Home-Based Care Solutions
- 4.2.3 Minimally Invasive Therapies
- 4.2.4 Telehealth & Remote Monitoring
- 4.2.5 Advanced Pulmonary Rehabilitation Programs

5. Emphysema Treatment Market Analysis Of End Use Industries

5.1 Clinics
5.2 Hospitals
5.3 Surgical Centres
5.4 Home Healthcare Providers
5.5 Pulmonary Rehabilitation Centers

6. Emphysema Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Emphysema Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Emphysema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Emphysema Treatment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Emphysema Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Emphysema Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Emphysema Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Emphysema Treatment Market Segmentation

9.1. Global Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
9.2. Global Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
9.3. Global Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinics, Surgical Centre, Other End-Users
9.4. Global Emphysema Treatment Market, Sub-Segmentation Of Smoking Cessation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
9.5. Global Emphysema Treatment Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
9.6. Global Emphysema Treatment Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
9.7. Global Emphysema Treatment Market, Sub-Segmentation Of Leukotriene Modifiers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Montelukast, Zafirlukast
9.8. Global Emphysema Treatment Market, Sub-Segmentation Of Supplemental Oxygen, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
9.9. Global Emphysema Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Macrolides, Fluoroquinolones, Tetracyclines
9.10. Global Emphysema Treatment Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gene Replacement Therapy, Antisense Oligonucleotides
9.11. Global Emphysema Treatment Market, Sub-Segmentation Of Surgery Transplant, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9.12. Global Emphysema Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

10. Emphysema Treatment Market Regional And Country Analysis

10.1. Global Emphysema Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Emphysema Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Emphysema Treatment Market

11.1. Asia-Pacific Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Emphysema Treatment Market

12.1. China Emphysema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Emphysema Treatment Market

13.1. India Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Emphysema Treatment Market

14.1. Japan Emphysema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Emphysema Treatment Market

15.1. Australia Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Emphysema Treatment Market

16.1. Indonesia Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Emphysema Treatment Market

17.1. South Korea Emphysema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Emphysema Treatment Market

18.1. Taiwan Emphysema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Emphysema Treatment Market

19.1. South East Asia Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Emphysema Treatment Market

20.1. Western Europe Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Emphysema Treatment Market

21.1. UK Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Emphysema Treatment Market

22.1. Germany Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Emphysema Treatment Market

23.1. France Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Emphysema Treatment Market

24.1. Italy Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Emphysema Treatment Market

25.1. Spain Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Emphysema Treatment Market

26.1. Eastern Europe Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Emphysema Treatment Market

27.1. Russia Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Emphysema Treatment Market

28.1. North America Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Emphysema Treatment Market

29.1. USA Emphysema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Emphysema Treatment Market

30.1. Canada Emphysema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Emphysema Treatment Market

31.1. South America Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Emphysema Treatment Market

32.1. Brazil Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Emphysema Treatment Market

33.1. Middle East Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Emphysema Treatment Market

34.1. Africa Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Emphysema Treatment Market, Segmentation By Treatment, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Emphysema Treatment Market Regulatory and Investment Landscape

36. Emphysema Treatment Market Competitive Landscape And Company Profiles

36.1. Emphysema Treatment Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Emphysema Treatment Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Emphysema Treatment Market Company Profiles
- 36.3.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

37. Emphysema Treatment Market Other Major And Innovative Companies

Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc.

38. Global Emphysema Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Emphysema Treatment Market

40. Emphysema Treatment Market High Potential Countries, Segments and Strategies

40.1 Emphysema Treatment Market In 2030 - Countries Offering Most New Opportunities
40.2 Emphysema Treatment Market In 2030 - Segments Offering Most New Opportunities
40.3 Emphysema Treatment Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer